Presentation is loading. Please wait.

Presentation is loading. Please wait.

HEMOSTASis Nada Mohamed Ahmed , MD, MT (ASCP)i.

Similar presentations


Presentation on theme: "HEMOSTASis Nada Mohamed Ahmed , MD, MT (ASCP)i."— Presentation transcript:

1 HEMOSTASis Nada Mohamed Ahmed , MD, MT (ASCP)i

2 Contents Normal hemostasis Primary hemostasis disorders

3 Haima + Stasis Prevent blood loss

4 Maintains blood flow Prevents bleeding

5 HEMOSTASIS Definition - Heme = blood - stasis = to halt
It is the process of forming clots in the wall of damaged blood vessels & preventing blood loss while maintaining blood in a fluid state with in the vascular system. Spontaneous arrest of bleeding by physiological process.

6 Formation of Platelet Plug Formation of blood clot
Stages of Hemostasis Vascular Constriction Formation of Platelet Plug Formation of blood clot Fibrinolysis

7 stages of primary hemostasis
Platelet Adhesion Platelet Activation Platelet Aggregation

8 platelet adhesion

9 Platelet activation : platelet release action

10 Platelet aggregation

11 Secondary hemostasis “Cascade of reactions” by Macfarlane, R.G.,1967
It states that ‘inactive’ enzymes are activated, and the ‘activated’ enzymes in turn activates other inactive enzymes until final step is reached.

12 Clotting Factors Factor I Fibrinogen Factor II Prothrombin Factor III
Thromboplastin Factor IV Calcium Factor V Labile factor, or proaccelerin Factor VI Non – existent Factor VII Stable factor or proconvertin Factor VIII Antihaemophilic factor / globulin A Factor IX Christmas factor or Antihaemophilic factor B Factor X Stuart – Prower factor Factor XI Plasma thromboplastin antecedent or Antihaemophilic factor C Factor XII Hageman factor or Contact factor Factor XIII Fibrin stabilizing factor or Laki – Lorand factor

13 Intrinsic Pathway

14 Conversion of Prothrombin to Thrombin & Fibrin Polymerization

15 Extrinsic Pathway

16

17 why blood does not clot in circulation ?
Endothelial surface factor -smoothness -layer of glycocalyx -Negatively charged Velocity of circulation Natural anticoagulants Activation of Fibrinolytic system Liver removes activated clotting factors

18 FIBINOLYSIS

19 Haemostatic (Bleeding) Disorders
Disease conditions characterized by excessive bleeding tendency due to defect in the haemostatic system, caused by: Vascular defects Platelet defects Coagulation defects Excessive fibrinolysis

20 Acquired Platelet Disorders Congenital Thrombocytopenia
(low platelet count) Thrombocytopathy (Abnormal Platelet function) Decreased production. Excessive destruction. Sequestration in the spleen. Acquired Drugs: Asprin Uremia Myeloproliferative disorders Multiple myeloma SLE Congenital Glanzman’s disease Bernard Soluier’s Storage granules defect

21 Thrombocytopenia caused by decreased platelet production
Congenital: Thrombocytopenia Aplastic anemia Acquired: States of Bone Marrow Failure: Aplastic Anemia Viral Infections Nutritional Deficiencies Chemotherapy & Radiation Therapy Infiltration of Abnormal Cells Leukemia. ,Metastatic Cancer.

22 Thrombocytopenia Excessive platelet destruction: Causes are :
.1- Drug induced thrombocytopenias. 2-Post-Transfusion (within 5 to 14 days) 2-Autoimmune Hemolytic Anemia/thrombocytopenia.

23 Thrombocytopathies (Abnormal Platelet Function) Inherited Qualitative Platelet Disorders may be due to abnormalities of platelet membrane glycoproteins, - Glanzmann Thrombastenia, abnormal GPIIb/IIIa – Bernard-Soulier Syndrome, abnormal GPIb, GPIX and GPV 2. platelet granules, These may occur due to absence of granules in platelets, storage pool disorder (characterized by disturbed platelet aggregation to collagen.

24 Acquired Disorders of Platelet Function (Cont…)
Drugs: Best example is ASPIRIN which is the MOST COMMON cause of acquired platelet function disorder. Aspirin irreversibly affect the cyclo-oxygenase enzyme. The effect last 4-7 days and it takes about 10 days before the platelets are replaced. Presents as elevated bleeding time but purpura is unusual.

25 Diagnosis Platelet count Bleeding time Specific Tests

26 Platelet Count 50,000 - 100,000 Mild Thrombocytopenia
NORMAL , ,000 CELLS/MM3 < 100, Thrombocytopenia 50, ,000 Mild Thrombocytopenia < 50, Sever Thrombocytopenia

27 Provides assessment of platelet count and function
Bleeding Time Provides assessment of platelet count and function Normal value 2-8 minutes

28 Specific Tests Tests for specific Platelet Functions.
Platelet aggregation test. Test for platelet secretion. Clot retraction test.

29 Clot Retraction Release of fibrin stabilizing factor
Contractile protein of platelets

30


Download ppt "HEMOSTASis Nada Mohamed Ahmed , MD, MT (ASCP)i."

Similar presentations


Ads by Google